Cel-Sci Overview
Latest P/E ratio for Cel-Sci: -0.6 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.60
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Cel-Sci (CVM) currently reports a P/E ratio of -0.6. That is below the Healthcare sector average of 25.9. Use the charts on this page to explore Cel-Sci's P/E ratio history and peer comparisons.
Cel-Sci's P/E ratio of -0.6 is lower than the Healthcare sector average of 25.9. That is roughly 102.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Cel-Sci's market price to a fundamental measure such as earnings, sales, or book value. At -0.6, CVM can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -0.6, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.9. From there, open related valuation or income-statement pages for Cel-Sci, and consider following CVM for alerts when major investors trade the stock.
Cel-Sci is classified in the Healthcare sector. On P/E ratio, it currently shows -0.6 versus a sector average near 25.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CVM with unrelated industries.
